Skip to content

Categories:

Category Archives: Food and Drug Administration

Fuad El-Hibri and the TAKREEM Achievement Awards November 7, 2011
Posted in Arab, Chief executive officer, Emergent BioSolutions, Food and Drug Administration, Fuad El-Hibri.
No comments
Emergent BioSolutions on Track to Complete Delivery of 14.5M Doses of BioThrax to the US Government Ahead of Schedule June 7, 2011
Posted in BioThrax, Chief executive officer, Emergent BioSolutions, Food and Drug Administration, Food and Drug Administration, Fuad El-Hibri.
No comments
Delegates from European Parliament Express Support for Rapid Development of New TB Vaccine March 3, 2011
Posted in Chief executive officer, Clinical trial, Emergent BioSolutions, Food and Drug Administration, Fuad El-Hibri.
No comments
CEO took roundabout path to Emergent January 7, 2011
Posted in Business, Chief executive officer, El-Hibri, Emergent BioSolutions, Entrepreneur, Food and Drug Administration, Fuad El-Hibri, Trubion Pharmaceuticals, United States, United States Department of Health and Human Services, Vaccine, Yale University, biotechnology.
No comments
Emergent BioSolutions Starts Phase I Clinical Trial for Third Generation Anthrax Vaccine January 4, 2011
Posted in BioThrax, Chief executive officer, Emergent BioSolutions, Food and Drug Administration, Fuad El-Hibri.
No comments
Fuad El-Hibri and the International Biomedical Research Alliance November 13, 2010
Posted in BioThrax, Chief executive officer, El-Hibri, Emergent BioSolutions, Food and Drug Administration, Fuad El-Hibri, United States.
No comments
Emergent BioSolutions Awarded HHS Contract Valued at up to $186.6 Million to Develop rPA Anthrax Vaccine September 20, 2010
Posted in BioThrax, Chief executive officer, Emergent BioSolutions, Food and Drug Administration, Fuad El-Hibri, United States, United States Department of Health and Human Services, Vaccine.
No comments
Emergent BioSolutions Awarded NIAID Contract That Increases Potential Funding to Over $58 Million for Advanced Development of Third Generation Anthrax Vaccine September 10, 2010
Posted in BioThrax, Chief executive officer, Emergent BioSolutions, Food and Drug Administration, Fuad El-Hibri, Vaccine.
No comments
Emergent BioSolutions to Acquire Trubion Pharmaceuticals August 18, 2010
Posted in BioThrax, Chief executive officer, Emergent BioSolutions, Food and Drug Administration, Fuad El-Hibri, Shareholders, Trubion Pharmaceuticals.
No comments
Emergent Revises Upward 2010 Financial Forecast August 3, 2010
Posted in BioThrax, Chief executive officer, Emergent BioSolutions, Food and Drug Administration, Fuad El-Hibri, Maryland, United States, Vaccine.
No comments
Maryland Governor Martin O’Malley Leads Ribbon Cutting Ceremony at Emergent’s Baltimore Manufacturing Facility July 27, 2010
Posted in BioThrax, Chief executive officer, Emergent BioSolutions, Food and Drug Administration, Fuad El-Hibri, United States, Vaccine.
No comments
Emergent BioSolutions Awarded HHS Contract Valued at Up to $107 Million to Develop Large-Scale Manufacturing for BioThrax July 15, 2010
Posted in BioThrax, Chief executive officer, Emergent BioSolutions, Food and Drug Administration, Fuad El-Hibri, United States, United States Department of Health and Human Services, Vaccine.
No comments
Emergent BioSolutions Hosts Biopreparedness Roundtable for NATO Parliamentarians July 13, 2010
Posted in BioThrax, Chief executive officer, Emergent BioSolutions, Food and Drug Administration, Food and Drug Administration, Fuad El-Hibri, United States Department of Defense, United States Department of Health and Human Services.
No comments
Emergent BioSolutions Completes Deliveries of BioThrax to Allied Foreign Governments July 7, 2010
Posted in BioThrax, Chief executive officer, Emergent BioSolutions, Food and Drug Administration, Fuad El-Hibri, United States, Washington.
No comments